Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
BMC Pulm Med ; 21(1): 333, 2021 Oct 26.
Artigo em Inglês | MEDLINE | ID: mdl-34702233

RESUMO

BACKGROUND: Recent studies report very low adherence of practitioners to ATS/IDSA recommendations for the treatment of nontuberculous mycobacteria pulmonary disease (NTM-PD), as well as a great variability of practices. Type of management could impact prognosis. METHODS: To evaluate management and prognosis of patients with NTM-PD cases with respect to ATS recommendations, we conducted a multicenter retrospective cohort study (18 sentinel sites distributed throughout France), over a period of six years. We collected clinical, radiological, microbiological characteristics, management and outcome of the patients (especially death or not). RESULTS: 477 patients with NTM-PD were included. Respiratory comorbidities were found in 68% of cases, tuberculosis sequelae in 31.4% of patients, and immunosuppression in 16.8% of cases. The three most common NTM species were Mycobacterium avium complex (60%), M. xenopi (20%) and M. kansasii (5.7%). Smear-positive was found in one third of NTM-PD. Nodulobronchiectatic forms were observed in 54.3% of cases, and cavitary forms in 19.1% of patients. Sixty-three percent of patients were treated, 72.4% of patients with smear-positive samples, and 57.5% of patients with smear-negative samples. Treatment was in adequacy with ATS guidelines in 73.5%. The 2-year mortality was 14.4%. In the Cox regression, treatment (HR = 0.51), age (HR = 1.02), and M. abscessus (3.19) appeared as the 3 significant independent prognostic factors. CONCLUSION: These findings highlight the adequacy between French practices and the ATS/IDSA guidelines. Treatment was associated with a better survival.


Assuntos
Pneumopatias/epidemiologia , Pneumopatias/microbiologia , Infecções por Mycobacterium/epidemiologia , Infecções por Mycobacterium/microbiologia , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Estudos de Coortes , Feminino , França/epidemiologia , Fidelidade a Diretrizes/estatística & dados numéricos , Humanos , Pneumopatias/diagnóstico por imagem , Pneumopatias/terapia , Masculino , Pessoa de Meia-Idade , Mycobacterium/isolamento & purificação , Infecções por Mycobacterium/diagnóstico por imagem , Infecções por Mycobacterium/terapia , Prognóstico , Estudos Retrospectivos , Distribuição por Sexo , Adulto Jovem
2.
Prog Urol ; 13(4): 700-2, 2003 Sep.
Artigo em Francês | MEDLINE | ID: mdl-14650311

RESUMO

The authors report a case of a 19-year-old man with alveolar rhabdomyosarcoma with an unusual clinical presentation. The diagnosis was established on lymph node biopsy performed on admission of the patient in a context simulating leukaemia. The patient achieved complete remission in response to high-dose chemotherapy. A recurrence in the form of an intratesticular metastasis demonstrated a periorbital tumour that was probably the primary tumour. The authors present the radiological and histological findings and a molecular biology study of the testicular metastasis, eliminating a primary testicular tumour.


Assuntos
Neoplasias Pulmonares/patologia , Alvéolos Pulmonares , Rabdomiossarcoma/secundário , Neoplasias Testiculares/secundário , Adulto , Humanos , Masculino , Rabdomiossarcoma/tratamento farmacológico , Neoplasias Testiculares/tratamento farmacológico
3.
Pneumologia ; 60(4): 222-4, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-22420173

RESUMO

Chronic necrotizing or semi-invasive aspergillosis represents a disease commonly occurred in patients with mild immunodeficiency. We report a case of chronic necrotizing pulmonary aspergillosis in immunocompetent patient without underlying disease. The discovery of the disease was made accidentally, by finding a nodular opacity on a routine chest X-ray. The diagnostic was confirmed by pathological and bacteriological examination. With specific antifungal treatment, no complete eradication was obtained and the patient has a slow evolution with many relapses.


Assuntos
Antifúngicos/uso terapêutico , Imunocompetência , Achados Incidentais , Aspergilose Pulmonar Invasiva/diagnóstico por imagem , Aspergilose Pulmonar Invasiva/patologia , Adulto , Caspofungina , Diagnóstico Diferencial , Quimioterapia Combinada , Equinocandinas/uso terapêutico , Feminino , Humanos , Aspergilose Pulmonar Invasiva/tratamento farmacológico , Aspergilose Pulmonar Invasiva/cirurgia , Itraconazol/uso terapêutico , Lipopeptídeos , Prognóstico , Pirimidinas/uso terapêutico , Radiografia , Doenças Raras , Recidiva , Cirurgia Torácica Vídeoassistida , Fatores de Tempo , Resultado do Tratamento , Triazóis/uso terapêutico , Voriconazol
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA